Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
Bias Likely Explains Link Between Antacids and Reduced Mortality in IPF Research
-
Bias Likely Explains Link Between Antacids and Reduced Mortality in IPF Research
A new review study suggests that a specific type of bias likely explains the reported benefits of antacid therapy in the survival of IPF patients.
Click here to read more about the impact of bias in IPF research.
What are your thoughts on this news? Do you think it’s possible to eliminate bias completely in research? How?
Sorry, there were no replies found.
Log in to reply.